Latest news
TG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings - simplywall.stsimplywall.st · Thu, 06 Aug 2026 08:14:06 GMTTG Therapeutics' BRIUMVI sales jump 64% YoY, bo... - PluangPluang · Mon, 03 Aug 2026 21:54:27 GMTTGTX Q2 Earnings Lag, Sales Rise Y/Y, 2026 View Raised, Stock Down - The Globe and MailThe Globe and Mail · Mon, 03 Aug 2026 16:50:00 GMTTGTX: Record BRIUMVI growth and raised guidance highlight a strong quarter and expanding franchise - TradingViewTradingView · Mon, 03 Aug 2026 14:37:33 GMTTG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance - TG TherapeuticsTG Therapeutics · Mon, 03 Aug 2026 14:18:06 GMTTG Therapeutics Raises 2026 Outlook Following Strong Briumvi Sales Growth - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:20:43 GMTTG Therapeutics raises 2026 revenue guidance af... - PluangPluang · Mon, 03 Aug 2026 12:08:52 GMTTG Therapeutics reports Q2 2026 revenue ~$240M, raises 2026 BRIUMVI U.S. revenue guidance - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMT